Abstract Using human airway epithelial cell lines (i.e. NCI-H441 and Calu-3) as well as human alveolar epithelial type Ilike (ATI) cells in primary culture, we studied the contribution of the epithelial sodium channel δ-subunit (δ-ENaC) to transepithelial sodium transport in human lung in vitro. Endogenous δ-ENaC protein was present in all three cell types tested; however, protein abundance was low, and no expression was detected in the apical cell membrane of these cells. Similarly, known modulators of δ-ENaC activity, such as capsazepine and icilin (activators) and Evans blue (inhibitor), did not show effects on short-circuit current (I SC ), suggesting that δ-ENaC is not involved in the modulation of transcellular sodium absorption in NCI-H441 cell monolayers. Overexpression of δ-ENaC in NCI-H441 cells resulted in detectable protein expression in the apical cell membrane, as well as capsazepine and icilin-stimulated increases in I SC that were effectively blocked by Evans blue and that were consistent with δ-ENaC activation and inhibition, respectively. Consequently, these observations suggest that δ-ENaC expression is low in NCI-H441, Calu-3, and ATI cells and does not contribute to transepithelial sodium absorption.
Introduction
The epithelial surface of the lungs is lined with the airway surface liquid (ASL). In the upper airways, an optimal height of ASL is a prerequisite for the mucociliary clearance. Concerted apical chloride secretion and sodium absorption, mainly mediated by the cystic fibrosis conductance regulator (CFTR) and epithelial sodium channels (ENaC), determine transepithelial water flow across the airway epithelial barrier and, consequently, the ASL height (~8 μm) [1] . In the alveoli, maintaining an extremely thin (~0.1 μm) layer of lining fluid is necessary to allow effective gas exchange [2] . Alveolar fluid clearance (AFC) is mainly driven by active sodium absorption via ENaC channels across the distal lung epithelium. Impaired AFC is associated with pathological conditions, i.e. the formation of pulmonary oedema [3] .
Four ENaC subunits, which share 27-37 % homology on amino acid level, have been described in mammals: the pore-forming α-and δ-as well as the accessory β-and γ-ENaC. The most obvious difference between these classic α-, β-and γ-ENaC subunits and δ-ENaC is their distinct tissue distribution. Alpha-, β-and γ-ENaC are abundantly expressed in sodium-absorbing epithelia of kidney, colon and lung and a number of other epithelia [4] [5] [6] [7] [8] . In contrast, the highest transcriptional expression levels of δ-ENaC were detected in nonepithelial tissues, such as brain, pancreas, heart, testis and ovary, whilst lung, kidney, colon and several other tissues showed only low expression [9, 10] . A new transcript, which was named ENaC δ 2 , was recently found to be expressed in several human tissues, including the CNS [11] . Additionally, the pharmacological and biophysical properties are clearly distinct between δ-and α-ENaC-generated currents. For example, δ-ENaC is about 30 times less sensitive to amiloride and its analogue, benzamil [K 0.5 (amiloride) =2.6 and 0.08 μM, K 0.5 (benzamil) =270 and 7 nM for δ-and α-ENaC, respectively), but more selective for sodium versus lithium, whereas α-ENaC is more selective for lithium versus sodium [9, 12] .
The physiological importance of α-, β-and γ-ENaC subunits in the lung has long been established. Alpha-ENaC is essential for AFC at birth, as neonatal α-ENaC knockout mice died from the inability to clear their lungs of fluid [13] . In adult rats, silencing of α-ENaC using small-interfering RNA (siRNA) reduced the basal AFC levels and abrogated the stimulation of AFC by β-agonists [14] . The roles of β-and γ-ENaC subunits in the alveoli appear less critical. Mice lacking β-or γ-ENaC were able to clear their lungs at birth but died from abnormal renal electrolyte re-absorption [15] [16] [17] .
Delta-ENaC has been found expressed in several human respiratory epithelial cell lines, i.e. A549, NCI-H441 and 16HBE14o-as well as in ATII cells in primary culture and in human lung tissue [18] [19] [20] . Moreover, Bangel-Ruland et al. [21] demonstrated the presence of δ-ENaC in primary human nasal epithelial cells (HNE). Since δ-ENaC physically interacts with α-and γ-subunits in NCI-H441 cells, and δαβγ-channels, heterologously expressed in Xenopus laevis oocytes, displayed biophysical and pharmacological characteristics (i.e. ion selectivity, single channel sodium conductance, affinity to amiloride, gating kinetics) distinct from those of αβγ-and δβγ-channels, it has been suggested that δ-ENaC may contribute to the variety of amiloridesensitive currents across the native alveolar epithelia by forming different combinations of heteromeric channels with classic ENaC subunits [12, 18] . Because the molecular basis for the distinct sodium conductances detected in native respiratory epithelial cells has not been identified, the possible contribution of δ-ENaC-generated currents to the net sodium transport is of a particular interest. However, the fact that δ-ENaC in rodents is a pseudogene hinders the development of experimental animal models; thus, in vitro approaches are currently the most promising to elucidate the physiological function of the ion channel [22] .
In this study, we aimed to test the hypothesis that δ-ENaC contributes to transepithelial ion transport, and to determine its physiological role in the human airway epithelium in vitro. To this end, we utilised common cell models of human lung epithelium, i.e. NCI-H441, a human lung adenocarcinoma cell line in which δ-ENaC expression has been described previously at both messenger RNA (mRNA) and protein levels [18, 19] , Calu-3, a human bronchial adenocarcinoma cell line, and human ATI-like cells in primary culture. To identify δ-ENaC-mediated currents, selective modulators of δ-ENaC function that have been characterised previously in X. laevis oocytes [23] [24] [25] were used. Whilst amiloride and benzamil only allow distinguishing between the channel complexes on the basis of the higher affinities to the α-subunit [9] , the δ-ENaC inhibitor, Evans blue (IC 50 = 143 μM), and the activators, capsazepine and icilin (EC 50 =8 μM and 33 μM, respectively), modulate δ-ENaC channel activity with only marginally affecting α-ENaC-mediated currents [23] [24] [25] . Here, we describe the δ-ENaC expression in human airway and alveolar epithelial cells and the paradoxical absence of δ-ENaCspecific activity in these cells in vitro.
Materials and methods

Materials
We used and compared two primary anti-δ-ENaC antibodies: a commercially available antibody raised against amino acids 81-310 near the N-terminus of human δ-ENaC (SC-21015, Santa Cruz Biotechnology, Heidelberg, Germany, termed anti-δ-N in this report) and an antibody raised against the C-terminus of the δ-ENaC protein (amino acids 563-638; this sequence is not conserved in other ENaC subunits, but common to both described δ-ENaC isoforms [11] , termed anti-δ-C in this report). For immunofluorescence microscopy, matching Alexa Fluor-488-labelled F(ab') 2 fragments were supplied by Invitrogen (Biosciences, Dun Laoghaire, Ireland). All cell culture plastics were obtained from Greiner BioOne (Frickenhausen, Germany), with the exception of Transwell Clear inserts (12 mm in diameter, pore size 0.4 μm; Corning, VWR, Dublin, Ireland). All cell culture media and reagents were from Sigma-Aldrich (Dublin, Ireland), apart from Gibco RPMI 1640 medium (Invitrogen) and Small Airway Growth Medium (SAGM, Lonza, Verviers, Belgium). All other chemicals and reagents were of the highest purity grade available and purchased from Sigma-Aldrich unless stated otherwise.
Cell culture
All cell types were cultured in a humidified atmosphere at 37°C in 5 % CO 2 . The medium was changed every other day. The transepithelial electrical resistance (TEER) of cell monolayers grown under liquid-covered conditions on Transwell Clear inserts was measured using a Millicell ERS Volt-Ohm meter equipped with STX-2 electrodes (Millipore, Carrigtwohill, Ireland) and corrected for the background value contributed by the Transwell Clear inserts and medium.
Human bronchial epithelial Calu-3 cells (ATCC HTB-55) were obtained from the European Collection of Animal Cell Cultures (ECACC, Salisbury, UK). Cells were seeded at a density of 100,000/cm 2 on Transwell Clear inserts and grown in Eagle's minimum essential medium (EMEM), supplemented with 10 % fetal bovine serum (FBS), 100 U/ml penicillin, 100 μM/ml streptomycin, 1 mM sodium pyruvate, 0.1 mM non-essential amino acids and 15 mM glucose. Ussing chamber studies were carried out on days 14-21 in culture, all other experiments on day 12.
The human bronchiolar epithelial NCI-H441 cell line (ATCC HTB-174) was purchased from LGC Standards, Teddington, UK. NCI-H441 cells were seeded at a density of 250,000/cm 2 on Transwell Clear inserts and cultured in Gibco RPMI 1640 medium, supplemented with 10 % FBS, 100 U/ml penicillin, 100 μM/ml streptomycin and 1 mM sodium pyruvate. Twenty-four hours post-seeding, the medium was replaced with RPMI medium additionally supplemented with 200 nM dexamethasone and ITS supplement (5 μg/ml insulin, 5 μg/ml transferrin, 5 ng/ml sodium selenite, Roche Diagnostics Limited, West Sussex, UK) [26] . Experiments with NCI-H441 cells were carried out on days 8-14 in culture.
Human embryonic kidney HEK-293 cells (ATCC CRL-1573) were obtained from ECACC and were grown in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10 % FBS, 100 U/ml penicillin and 100 μM/ml streptomycin.
Human alveolar epithelial cell isolation and culture
Human alveolar type II (ATII) epithelial cells were freshly isolated from non-tumour lung tissue obtained from patients undergoing lung resection. The use of human material was approved by Saarland State Medical Board, Germany. Isolation of ATII was performed according to a protocol adapted from Ehrhardt et al. [27] . Purified ATII cells were seeded at a density of 600,000 cells/cm 2 on collagen and fibronectin-coated plastics using complete SAGM medium supplemented with 100 U/ml penicillin, 100 μM/ml streptomycin and 1 % FBS. Primary cells were used after transdifferentiation into monolayers of type I-like (ATIlike) phenotype, following 8 days of culture [28] .
Cell transfection
Plasmid transfection
The generation of the expression plasmid containing human δ 1 -ENaC cDNA in a pcDNA™ 3.1(+) vector is described in detail elsewhere [29] . NCI-H441 and HEK-293 cells were transfected using Lipofectamine 2000 transfection reagent (Invitrogen) following the manufacturer's protocol. To determine transient δ-ENaC over-expression, protein samples were collected 48 h after transfection, quantified and analysed by Western blot.
Generation of a stably δ-ENaC over-expressing cell line Forty-eight hours post-transfection with δ 1 -ENaC plasmid, NCI-H441 cells were split into medium containing 600 μg/ml geneticin (G418, Sigma-Aldrich) and 10 μM benzamil. The G418 concentration of 600 μg/ml was previously shown to be suitable for selection. Several G418-resistant colonies were picked, expanded and assessed for δ-ENaC expression by Western blot. Colonies stably expressing δ-ENaC were kept in culture using the geneticin/benzamil supplemented medium, and cells deriving thereof were used for subsequent expression and functional studies.
Western blot
Cell cultures were lysed on ice using cell extraction buffer (Invitrogen) supplemented with protease-inhibitor cocktail (Sigma-Aldrich). Cell lysates were then briefly sonicated and centrifuged (10,000g at 4°C) for 20 min. The protein concentrations of the obtained supernatants were determined using a standard protein assay (Bio-Rad, Hemel Hempstead, UK) according to the manufacturer's instructions. Samples were loaded at equal protein concentrations, separated by electrophoresis using 8.5 % polyacrylamide gels, and subsequently transferred to immunoblot polyvinylidene fluoride membranes (Bio-Rad). Membranes were blocked in phosphatebuffered saline containing 5 % bovine serum albumin (BSA) and 0.1 % Tween 20 (pH 7.4) at 4°C overnight. Incubation with the respective primary antibody for 2 h at room temperature (i.e. Na + /K + -ATPase; anti-δ-C 1:5000 and β-actin 1:8000) was followed by 1 h incubation with horseradish peroxidase (HRP)-conjugated secondary antibodies at room temperature (at 1:12,500 dilution). Peroxidase activity was detected with Immobilon Western Chemiluminescent HRP substrate (Millipore). Relative levels of protein expression were quantified by densitometric analysis of the immunoblot using a ChemiDoc documentation system (Bio-Rad). To ensure equal loading, protein was normalised to β-actin. Protein samples obtained from wild-type and mock-transfected HEK-293 cells were used as negative controls. Positive controls were lysates from HEK-293 cells transiently transfected with the fulllength δ 1 -ENaC plasmid.
Biotinylation of cell surface proteins
Confluent, Transwell-grown cell monolayers were washed with ice-cold phosphate-buffered saline (PBS) containing 2.0 mM CaCl 2 . Sulfo-NHS-biotin (0.5 mg/ml, Thermo Scientific Pierce, Medical Supply Company, Dublin, Ireland) was then applied to the apical or basolateral compartments of the monolayers. Phosphate-buffered saline supplemented with 10 % BSA and 2.0 mM CaCl 2 was added to the respective opposite compartments, to prevent biotinylation of the opposite cell surface. After 20 min incubation at 4°C, 10 % BSA in PBS was added to both compartments to stop the biotinylation reaction, and cell monolayers were incubated for another 20 min. Following cell lysis, protein concentrations of the whole cell lysates were determined by Bradford assay, and equal amounts of protein were loaded onto streptavidin-agarose beads (500 μg whole-cell protein/100 μl streptavidinagarose beads) for overnight incubation at 4°C. The next day, biotinylated membrane proteins, now bound onto beads, were separated from the non-biotinylated proteins by centrifugation, washed, resuspended in protein loading buffer and used for Western blot.
Protein deglycosylation
GlycoProfile II, Enzymatic In-Solution N-Deglycosylation kit (PP0201, Sigma-Aldrich), was used according to manufacturer's instructions. Briefly, protein samples were denaturated by incubation with denaturant solution containing 2 % octyl-β-D-glucopyranoside and 100 mM β-mercaptoethanol at 100°C for 10 min and diluted to the final protein concentration of 1 mg/ml. Peptide N-glycosidase F (PNGase F) was added at the concentration of 50 U/ml. Equal volumes of water were added to the untreated control samples. After 6 h of incubation at 37°C, the reaction was stopped by heating at 100°C for 10 min. Aliquots of PNGase F treated samples and untreated controls were used for subsequent analysis by Western blot.
Immunofluorescence microscopy
Transwell-grown cell monolayers were fixed by 10-min incubation with ice-cold methanol, followed by permeabilisation with 0.1 % Triton X-100 for 8 min. Unspecific binding sites were blocked by incubation with PBS containing 5 % BSA for 30 min at 37°C. After 60 min incubation at 37°C with a 1:50 dilution of the anti-δ-ENaC antibody in PBS containing 1 % BSA, the cell layers were washed three times with PBS (1 % BSA). Subsequently, cells were incubated for 30 min at 37°C with a 1:1000 dilution of Alexa Fluor-488-labelled F(ab') 2 fragment in PBS containing 1 % BSA. Nuclei were counterstained with propidium iodide (1 μg/ml in PBS). The specimens were then washed three times with PBS (1 % BSA) and embedded in FluorSave anti-fade medium (Merck, Nottingham, UK). Images were obtained using a confocal laser scanning microscope (CLSM, Zeiss LSM 510, Göttingen, Germany). The same pinhole settings and the detector gains were used to detect and compare the signals obtained in the wildtype and δ-ENaC over-expressing NCI-H441 cells. Cell monolayers stained with the secondary antibodies only were used as background controls.
Ussing chamber studies
Transwell-grown cell monolayers were regarded as suitable for the transepithelial measurements when the net TEER values exceeded 300Ω cm 2 . Confluent cell monolayers were mounted into modified Ussing chambers. Krebs-RingerBuffer pH 7.4 was added to both compartments of the chamber (composition of KRB: 116.4 mM NaCl, 5.4 mM KCl, 0.78 mM NaH 2 PO 4 , 25 mM NaHCO 3 , 5.55 mM glucose, 15 mM HEPES, 1.8 mM CaCl 2 , 0.81 mM MgSO 4 ). Sodium-free solutions contained equivalent amounts of KCl, KH 2 PO 4 and KHCO 3 , respectively, whereas in Cl --free solutions, equivalent amounts of the relevant gluconate salts were used.
Chambers and bathing solutions were maintained at 37°C and continuously stirred. The transepithelial potential difference (PD) was clamped to 0.0 mV using a standard fourelectrode voltage clamp (DVC-1000, World Precision Instruments, Sarasota, FL, USA), and the short-circuit current (I SC ) was continuously recorded using Chart5 for Windows (ADInstruments, Oxfordshire, UK). Voltage impulses of 0.5 mV were given every 50 s in order to monitor the TEER of cell monolayers. Cell monolayers were allowed to reach steady-state basal I SC before the compound of interest was added. The used stock solutions were 50 mM Evans blue, 5 mM capsazepine, 10 mM icilin, 2.5 mM CFTR(inh) 172 , 50 mM amiloride and 100 mM ouabain (all in DMSO; all from Sigma-Aldrich).
Statistical analysis
All experiments were carried out at least in triplicate using cells from at least three different passages. Results, all given as means±SD, were compared using one-way analysis of variance (ANOVA), followed by the Student-Newman-Keuls post hoc test. P<0.05 was considered significant.
Results
Expression of δ-ENaC in human respiratory epithelial cells
Immunoblots from Calu-3, NCI-H441 and ATI-like cell lysates as well as negative and positive controls were probed with two different antibodies, i.e. anti-δ-N and anti-δ-C. The anti-δ-N antibody revealed identical band patterns for nontransfected, mock-transfected and δ 1 -ENaC over-expressing HEK-293 cells (Supplementary Material Figure S1 ). Due to this unreliability, further studies were carried out using only the anti-δ-C antibody.
An unspecific band at 100 kDa was observed in all cell lysates (Fig. 1a) . Nevertheless, a strong band at approximately 70-85 kDa was found in the δ 1 -ENaC over-expressing HEK-293 cell lysates. This band possibly represented merged double bands of δ-ENaC protein at 75 kDa and its glycosylated form at 86 kDa [30] . In lysates from Calu-3, NCI-H441 and ATI-like cells, multiple protein bands were observed, at 200 (Calu-3 only), 100 and 75 kDa as well as further protein bands at lower molecular weights. The band at 75 kDa was weak but corresponded to the δ 1 -ENaC band in over-expressing HEK-293 cells. The presence of this band in all three respiratory epithelial cell types tested confirmed δ-ENaC protein synthesis in these cells.
Localisation of δ-ENaC in human respiratory epithelial cells
Immunofluorescence images showing the subcellular localisation of the δ-ENaC protein are depicted in Fig. 1b-d . Transepithelial electrical resistance values, measured prior to fixation and permeabilisation procedure, were >300Ω cm 2 in all cases. Additionally, staining for Na + /K + -ATPase, as a basolateral marker, and for the tight-junctional protein, ZO-1, confirmed polarised cell monolayers with well-developed cellular contacts (data not shown).
Immunofluorescence micrographs showed a mainly intracellular protein localisation. The punctate character of the staining suggests vesicular localisation of the detected protein. The localisation pattern of the signal was different in NCI-H441 and ATI-like versus Calu-3 cells. The signal was predominantly perinuclear in NCI-H441 and ATI-like cells, but accumulated primarily along the cell borders in Calu-3 cells. Effects of modulators of δ-ENaC activity in human respiratory epithelial cells
We used a pharmacological approach to test for functional δ-ENaC activity in human respiratory epithelium in vitro. The δ-ENaC inhibitor, Evans blue (EB), was added to the apical side of the Ussing chamber and increased basal I SC across Calu-3 cell monolayers [by 116.8 ± 36.2 % (100 μM) and 269.1 ± 114.5 % (300 μM), respectively (Fig. 2a, c) ]. In contrast, in NCI-H441 cell monolayers, EB decreased I SC in a concentration-dependent manner by 56.4±11.9 % (100 μM) and 70.0±14.9 % (300 μM) of basal I SC (Fig. 2b, c) . ATI-like primary cell monolayers responded similarly to EB, i.e. 62.5±10.0 % and 76.3± 4.2 % of the basal I SC were blocked by 100 and 300 μM EB (Fig. 2b, c) . After removal of the EB-containing solution, short-circuit currents returned to basal levels (data not shown).
The δ-ENaC activator, capsazepine inhibited basal I SC in a concentration-dependent manner in all three cell types tested (Fig. 3a-c) . The inhibition reached a maximum of 40.3± 11.5 % in Calu-3, 29.4±6.4 in NCI-H441 and 43.5±21.3 % in ATI-like cells.
Apical administration of the δ-ENaC activator, icilin led to a concentration-dependent increase in I SC in Calu-3 cell monolayers with current activation of 79.0 ± 29.4 % by 60 μM icilin (Fig. 3d, f) . Inhibitory effects of icilin of 20.3±5.6 and 43.6±12.8 % on I SC were observed in NCI-H441 and ATI-like cells, respectively (Fig. 3e, f) .
Ion dependencies of the effects, induced by δ-ENaC modulators in human respiratory epithelial cells
We determined whether effects caused by the δ-ENaC modulators were dependent on sodium or chloride transport. Figure 4a summarises the impact of sodium removal and the inhibition of amiloride-sensitive channels, on the short circuit current in NCI-H441 cell monolayers. Basal I SC was significantly reduced from 8.8±3.3 μA/cm 2 to 0.1 ±0.6 μA/cm 2 following sodium removal from the bathing solution. Addition of amiloride (10 μM) also abolished I SC to 0.8±0.4 μA/cm 2 . EB (300 μM) significantly decreased I SC from 8.2±3.5 to 2.4±1.4 μA/cm 2 . Addition of 10 μM amiloride led to a further significant reduction to 0.5 ± 0.5 μA/cm 2 . I SC values measured after application of both EB and amiloride were not significantly different from values obtained following addition of amiloride alone. In sodium-free bathing solution, administration of EB did not have a significant effect on I SC . Capsazepine at 20 μM decreased I SC from 7.6±3.5 to 5.1±2.5 μA/cm 2 . Addition of 10 μM amiloride reduced the I SC further to 0.3±0.2 μA/ cm 2 . In the absence of sodium, no significant capsazepine effect was observed. Icilin produced a fall in I SC from 9.0± 4.2 to 7.2±3.2 μA/cm 2 at 60 μM but failed to produce a significant effect in sodium-free KRB. When amiloride was added after icilin, an additional inhibition of shortcircuit current was observed. Again, the resulting values were not significantly different from the I SC inhibited by amiloride alone. In summary, these measurements indicate Fig. 2 Representative shortcircuit current (I SC ) traces obtained in response to the subsequent apical administration of 100 and 300 μM Evans blue (EB) to the monolayers of a Calu-3 and b NCI-H441 and ATI-like cells: δ-ENaC inhibitor EB increased I SC across Calu-3 cell monolayers, but had an inhibiting effect on the I SC in NCI-H441 and ATI-like cells. c Short-circuit current levels were measured 15 min after adding the compound and normalised by the basal I SC in the absence of EB. Results are expressed as means± SD (n=3-13). The statistical significance of the effect is expressed as *P<0.01, versus the basal I SC , and as # P<0.01 versus the I SC in response to 100 μM EB that EB, capsazepine and icilin exerted inhibitory effects on amiloride-sensitive sodium currents in NCI-H441 cells.
In Calu-3 cell monolayers, effects induced by these δ-ENaC modulators were also sodium dependent, but not amiloride sensitive (data not shown). To test whether CFTR and chloride transport play a role in the observed effects of EB, capsazepine and icilin, measurements were performed in chloride-free conditions and in the presence of the CFTR inhibitor, CFTR(inh) 172 (Fig. 4b) . Removal of chloride ions led to a significant decrease in I SC from 6.2±1.6 to 1.9±2.8 μA/ cm 2 . Moreover, 69.8±16.7 % of the basal I SC was blocked by addition of 10 μM of the CFTR channel inhibitor, CFTR(inh) 172 . Short-circuit currents after application of CFTR(inh) 172 were not significantly different from those measured in chloride-free KRB. EB significantly increased I SC from 6.9±2.4 to 14.9±3.7 μA/cm 2 (measured 15 min after adding the compound). In chloride-free medium, no significant activation of I SC by EB was observed. The presence of CFTR(inh) 172 did not abolish the increase in current caused by EB. When added after CFTR(inh) 172 , EB increased the I SC to 16.8±1.0 μA/cm . In summary, the obtained results suggested that the currents activated by EB and icilin in Calu-3 cells were chloride dependent. Nevertheless, while the effects of icilin appeared as mediated by CFTR, the effect of EB was CFTR independent. The decrease in I SC induced by capsazepine was both chloride and CFTR independent.
Knockdown and over-expression of δ-ENaC in human respiratory epithelial cells
In order to test whether the stimulatory/inhibitory effects observed with the alleged δ-ENaC modulators were the result of a specific and exclusive interaction with δ-ENaC, RNA interference (RNAi) technique was used to transiently (using siRNA) and stably (using shRNA) transfect NCI-H441 and Calu-3 cells to down-regulate expression of δ-ENaC (see Supplementary Material). However, neither RNAi technique Fig. 4 a Sodium dependence of the apical response to 300 μM EB, 20 μM capsazepine and 60 μM icilin in NCI-H441 cells. Results are expressed as means± SD (n=3-9). The statistical significance of the differences is expressed as *P<0.01 versus the basal I SC in KRB buffer, and the I SC in the presence of the relevant compound, respectively. b Effects of chloride ion removal as well as of inhibition of CFTR-mediated currents on the apical response to 100 μM EB, 20 μM capsazepine and 60 μM icilin in Calu-3 cells. I SC values were measured 15 min after addition of the compounds. Results are expressed as means± SD (n=3-20). The statistical significance of the differences is expressed as *P<0.01 versus the basal I SC , I SC in the presence of the relevant compound or 10 μM CFTR(inh) 172 , respectively. Superscript 1 substance was added first, superscript 2 substance was added 30 min after the first compound resulted in a significant further decrease in δ-ENaC protein (from already low levels at baseline) (Supplementary Material Figure S2 ). Moreover, effects of the δ-ENaC modulators on the currents in transfected Calu-3 and NCI-H441 cells were comparable to those in the respective non-transfected and mock-transfected cells (Supplementary Material Figure S3 ).
Expression and localisation of δ 1 -ENaC protein over-expressed in NCI-H441 cells
In cell lysates from δ-ENaC over-expressing NCI-H441 cells, a prominent protein band was detected at 75 kDa. In addition, a band at 70 kDa, only occasionally observed in wild-type NCI-H441 cells, appeared consistently in all samples from transfected cells (Fig. 5a-c) . Following PNGase F treatment, the main band shifted from 75 to 70 kDa (Fig. 5d) , attesting that these bands represented N-glycosylated and nonglycosylated forms of the over-expressed δ 1 -ENaC protein.
To study the localisation of the over-expressed δ 1 -ENaC protein, NCI-H441 cells were grown on Transwell inserts and immunostained using the anti-δ-C antibody. Higher intensity as well as clearly changed distribution pattern of the fluorescent signal was observed in the δ 1 -ENaC over-expressing (Fig. 6b ) compared to that in the wild-type cells (Fig. 6a) . A strong accumulation of the fluorescent signal for the overexpressed δ-ENaC was observed at the apical surfaces of the transfected cells. To further confirm the localisation of δ-ENaC protein, apical and basolateral surface proteins of confluent NCI-H441 cell monolayers grown on Transwell inserts were biotinylated and analysed by Western blot. No δ-ENaC protein was detected in the biotinylated membrane protein fractions of wild-type cells (Fig. 6c) . Similar observations were made for ATI-like cell monolayers (data not shown). In apical and basolateral membrane fractions of Calu-3 cells, a band at 36 kDa was visible (data not shown). In contrast, the N-glycosylated 75 kDa form of δ-ENaC was detected on both cellular aspects of the transfected cells. The non-glycosylated form of 70 kDa was only observed in the basolateral membrane fraction (Fig. 6d) . This discrepancy may, however, be an artefact originating from less efficient recovery of the apically biotinylated protein samples. Effects of δ-ENaC modulators on the I SC in δ 1 -ENaC over-expressing NCI-H441 cells Evans blue, capsazepine and icilin showed pronounced effects on I SC in δ 1 -ENaC over-expressing NCI-H441 cells. In Fig. 8d -f, representative current traces in response to EB (300 μM), capsazepine (20 μM) and icilin (60 μM) are shown. EB led to a significant reduction of I SC , which was Fig. 9 ). Both activators of δ-ENaC function, capsazepine and icilin, augmented I SC levels in δ 1 -ENaC over-expressing NCI-H441 cells (significant activation by 33.0±7.7 % and 30.4±10.1 %, respectively), contrary to their inhibitory effect exhibited in wild-type cells (Fig. 9) . In summary, the effects in δ-ENaC over-expressing NCI-H441 cells were consistent with the original observation on the compounds using X. laevis oocytes [23] [24] [25] .
Amiloride sensitivity of the effects induced by δ-ENaC modulators in δ 1 -ENaC over-expressing NCI-H441 cells Figure 10a shows the effects of 10 and 100 μM amiloride on the I SC of δ 1 -ENaC over-expressing NCI-H441 cell monolayers, which have previously been treated with EB (300 μM), capsazepine (20 μM) or icilin (60 μM). Shortcircuit currents inhibited by EB (28.9±16.3 % of basal I SC values) were slightly decreased by the addition of 10 and 100 μM amiloride (24.3±18.6 % and 20.8±18.2 % of basal I SC , respectively). Capsazepine and icilin-induced increases in I SC (by 34.4±8.4 % and 31.3±11.8 % of basal I SC , respectively) were completely abolished by the administration of 10 μM amiloride (90.6±8.2 % and 72.6±6.7 % of the basal I SC , respectively). Subsequent increase to 100 μM amiloride led to a further significant decrease in I SC (49.4±18.6 % and 21.5± 14.5 % of the basal I SC , respectively). On the other hand, addition of capsazepine or icilin significantly stimulated currents across cell monolayers pre-treated with 10 μM amiloride (by 11.3±5.2 % and 12.5±2.6 % of the amiloride-insensitive I SC , respectively), albeit the amplitudes of the increases were significantly smaller than in the absence of amiloride (Fig. 10b) . Similar results were obtained with icilin ( Fig. 11c-e) . In the presence of EB, no significant current stimulation by icilin was observed. On the contrary, icilin further reduced I SC levels already diminished by EB (from 24.2±17.2 % to 20.2± 18.0 % of the basal I SC ), albeit the effect did not reach significance. Currents initially activated by icilin (28.5±7.1 %) were significantly reduced by EB. The resulting I SC value (i.e. 11.3±4.6 % of basal I SC ) was not significantly different from I SC in the presence of EB alone (29.9±19.1 %).
Discussion
There is a growing body of evidence confirming the presence of the δ-ENaC subunit in human respiratory epithelium. Delta-ENaC mRNA transcripts and protein have been detected in various continuously growing respiratory epithelial cell lines (i.e. A549, NCI-H441 and 16HBE14o-), freshly isolated respiratory epithelial cells in primary culture (ATI, ATII, HNE) and human lung tissue in situ [18] [19] [20] [21] . As a functional role of δ-ENaC in these epithelia, contribution to transepithelial sodium transport in human alveolar epithelium in health and disease has been suggested [12] . However, as with most other postulates regarding δ-ENaC function, this hypothesis is based on functional data acquired in δ-ENaC expressing X. laevis oocytes [18] . Supportive evidence in organotypic models is limited to two reports [21, 31] . The absence of δ-ENaC gene expression in rodents, where it is probably a pseudogene [22] , hinders the development of experimental animal models to study the physiological relevance of δ-ENaC in a more complex system.
In this work, organotypic cell models of respiratory epithelium, commonly employed to investigate pulmonary solute and ion transport in the airways, were used to study the functional expression of δ-ENaC in vitro, i.e. NCI-H441 and Calu-3 cell lines as well as the human alveolar epithelial type I-like cells in primary culture. Whilst both δ-ENaC mRNA and protein have been detected in NCI-H441 cells and human lung tissue [18] [19] [20] , δ-ENaC expression in Calu-3 bronchial epithelial cells has not been yet reported.
Delta-ENaC expression and localisation
In the literature, distinct molecular weights have been reported for the δ-ENaC protein detected by Western blot. The observed differences appear to depend on the type of the experimental model used. In particular, the protein processing, cleavage and glycosylation may differ between endogenously Fig. 7 Representative I SC traces obtained in response to subsequent administration of 10 and 100 μM amiloride in the a wild-type and b δ 1 -ENaC over-expressing NCI-H441 cells. c Quantification of the responses to 10 and 100 μM amiloride as well as to 1 mM ouabain. Short-circuit current values were measured after adding the respective concentration of amiloride or ouabain and normalised against the I SC , measured in the absence of the compounds (I SC basal). Results are expressed as means± SD (n=3-9). The statistical significance of the differences is expressed as *P<0.05 and as **P<0.01 versus the basal I SC , the I SC in the presence of 10 μM amiloride and versus the respective I SC in the wild-type NCI-H441 cells and heterologously expressed proteins. Moreover, differences between various expression systems, i.e. X. laevis oocytes versus HEK-293 cells, and organ systems, i.e. the skin versus the lung, may not be excluded. For the endogenous δ-ENaC, a single protein band was observed in samples from human skin and keratinocytes (~70 kDa, [32] as well as mouse sperm (~80 kDa, [33] , whilst a double band at 80-90 kDa was detected in the lysates of human bronchiolar epithelial NCI-H441 and pleural mesothelial M9K cells [34] as well as in the human glioma D54-MG cell line [35] . In addition, for heterologously expressed δ-ENaC, products of various molecular sizes have been reported. In CHO cells, a single 70 kDa δ-ENaC protein was observed [32] . In COS-7 cells, two δ-ENaC-specific bands at 85 and 95 kDa appeared, with the upper band shifting downwards to 90 kDa following the PNGase F treatment [36] . In X. laevis oocytes expressing δ-ENaC, on the other hand [30] , detected two prominent bands at 75 and 86 kDa, representing an N-glycosylated and a nonglycosylated form of the same protein.
With the anti-δ-C antibody, a protein of approximately 75 kDa was detected in lysates of HEK-293 cells, heterologously expressing δ-ENaC. Faint bands at the corresponding molecular weight were also observed in the whole cell lysates of Calu-3, NCI-H441 and ATI-like cells. Unexpectedly, only low δ-ENaC signals were detected in cell membranes by means of the immunofluorescence microscopy with either of the antibodies, revealing an intracellular, most likely vesicular localisation of δ-ENaC protein in NCI-H441, Calu-3 and ATIlike cells. Cell surface biotinylation confirmed the absence of δ-ENaC from the cell surface of NCI-H441 cells.
Effects of pharmacological modulators of δ-ENaC function on the I SC in human respiratory epithelial cells in vitro Three substances have been reported to be able to extract δ-ENaC-mediated currents from the αβγ-ENaC-mediated sodium transport. Evans blue (IC 50 =143 μM), capsazepine and icilin (EC 50 =8 μM and 33 μM, respectively) inhibited/ Fig. 8 Representative I SC traces of the responses to a, d 300 μM EB, b, e 20 μM capsazepine and c, f 60 μM icilin are shown, after the compounds were applied apically to the monolayers of the wild-type (a-c) or δ 1 -ENaC over-expressing NCI-H441 cells (d-f). All alleged δ-ENaC modulators exhibited inhibitory effects in the wild-type NCI-H441 cells. In δ 1 -ENaC over-expressing cells, only the δ-ENaC inhibitor, EB, decreased the I SC levels. The reported activators, capsazepine and icilin, had stimulatory effects on the I SC stimulated δ-ENaC activity in X. laevis oocytes expression system, without having an impact on α-ENaC [23] [24] [25] . Only a single publication, however, reported the use of these compounds as modulators of δ-ENaC function in an organotypic in vitro model, i.e. in human nasal epithelial (HNE) cells [21] . No functional evidence has yet been provided for other respiratory epithelial cell types, in particular NCI-H441 cells, for which δ-ENaC expression has been reported repeatedly [18, 19, 34] .
In our hands, Evans blue reduced currents across both NCI-H441 and ATI-like cell monolayers, which was consistent with previous observations in oocytes [25] and HNE cells [21] , but exhibited concentration-dependent stimulatory effects on the I SC in Calu-3 cells. Capsazepine, on the other hand, decreased the I SC in all cell types tested, albeit being suggested as a δ-ENaC activator [23] . Icilin, another reported activator [24] , caused a concentration-dependent I SC increase in Calu-3 cell monolayers, but exhibited inhibitory effects in NCI-H441 and ATI-like cell monolayers.
All three substances are known to modulate targets other than δ-ENaC in vitro and in situ. Capsazepine, for example, acts as a competitive antagonist on both TRPV1 and TRPM8 receptors [37, 38] , whereas icilin as a Bsuper-cooling agentâ ctivates TRPM8 [39] . Expression of both TRPV1 and TRPM8 receptors has been reported in human respiratory epithelial cells, so that their regulation by capsazepine and icilin Capsazepine (20 μM) or icilin (60 μM) were added to the cell monolayers in the presence or absence of 10 μM amiloride. I SC values were measured after adding the relevant compound and normalised against the I SC , measured prior to adding the substance (by basal I SC in the absence of amiloride/black bars or by I SC in the presence of 10 μM amiloride/grey bars). Results are expressed as means±SD (n=3-9). The statistical significance of the effect is expressed as *P<0.05 and **P<0.01 versus the basal I SC or the I SC in the presence of 10 μM amiloride, respectively, and as # P<0.01 versus the compound effect in the absence of amiloride may account for the outcomes observed with these compounds. Hence, despite the absence of direct evidence, it is conceivable that these ion channels may be differentially expressed in bronchial Calu-3, bronchiolar H441 and ATIlike cells, with inhibition of TRPM8 and TRPV1 by capsazepine and activation of TRPM8 by icilin leading to the respective inhibitory or stimulatory effects. Moreover, capsazepine also blocks voltage-dependent potassium channels [40] . Expression of the latter has been reported in rat alveolar epithelial cells in primary culture and in Calu-3 cells with localisation at the apical cell surfaces [41] , offering an alternative explanation for the observed capsazepine-induced I SC decreases in Calu-3, H441 and ATI-like cell monolayers. Among the substances tested, EB is probably the least specific compound, since it has been reported to interact with a range of different proteins. Besides δ-ENaC, it inhibits P 2 Xpurinergic receptors and glutamate transporters [42] . Activation of large conductance, Ca 2+ -activated K + channels (BK), is another mode of action exhibited by EB [43] . Functional BK channels have been most recently described at the apical surfaces of NHBE cells [44] . Importantly, not only did activation of the latter stimulate the apical K + secretion in NHBE cells, it also triggered an increase in apical Cl -efflux, suggesting that current stimulation by EB in Calu-3 cells may indeed occur via BK channels. Ultimately, it is beyond the scope of this work to identify the exact molecular pathways leading to the observed, pharmacological effects. Nevertheless, it is noteworthy to highlight the potential relevance of further investigating the nature of EB-induced increases in I SC in Calu-3 cells, as the Fig. 11 Capsazepine-and icilininduced I SC increases were sensitive to EB in δ 1 -ENaC overexpressing NCI-H441 cell monolayers. Representative I SC traces in response to consecutive administration of the δ-ENaC activator (a 20 μM capsazepine, c 60 μM icilin) and 300 μM EB and vice versa (c and d, respectively) . e I SC values were measured after administration of the respective compound and normalised against the I SC , measured in the absence of the substances (I SC basal). Results are expressed as means±SD (n=3). The statistical significance of the effect is expressed as n.s. non-significant and as *P<0.01 versus the I SC in the presence of capsazepine, icilin or EB. Superscript 1 substance was added first; superscript 2 substance was added 10 min after the first compound underlying mechanism could serve as a novel therapeutic approach in the treatment of cystic fibrosis.
Delta-ENaC over-expression studies Delta-ENaC was stably over-expressed in NCI-H441 cells. The specific δ-ENaC protein band at 75 kDa was of a significantly higher intensity in the transfected cells, and was demonstrated to be an N-glycosylated form of a 70-kDa protein, which was consistent with the previous reports of δ-ENaC protein being N-glycosylated [30, 36] . Moreover, elevated protein levels led to an increased insertion into the apical cell membrane, as confirmed by immunofluorescence microscopy (IFM). Conflicting data generated by surface biotinylation, which showed the over-expressed protein on both membranes, is likely an artefact [45] .
In the Ussing chamber studies, sodium currents across δ-ENaC over-expressing cell monolayers displayed significantly lower sensitivities to amiloride than in the wild-type cells. Expectedly, EB exhibited inhibitory effects on the I SC in δ-ENaC over-expressing cells. Capsazepine and icilin, on the other hand, increased the I SC levels, in agreement with the characterisation of both compounds as δ-ENaC activators [23, 24] and opposed to the current reduction observed with both substances in the wild-type cells. Highly selective sodium channels (HSCs), with a large selectivity for sodium over potassium, poorly selective channels displaying moderate selectivity as well as the non-selective cation channels (NSC) have been defined in the alveolar epithelial cells by single channel measurements and are responsible for the alveolar transepithelial sodium transport [46] . While the classic αβγ-ENaC is believed to represent the HSC, the molecular basis of the two other groups has remained controversial, with homomeric α-ENaC channels, αβ-or αγ-ENaC channels as well as different combinations of subunits with δ-ENaC being the potential candidates [18, 46] . Distinct affinities to the ENaC blocker amiloride also account for biophysical differences between the different channel types. In NCI-H441 cells, the presence of two populations of Na + channels (HSC and NSC) has been described, with~55 % of total I SC being sensitive to 1 μM amiloride, further 30 and 5 % being inhibited by 10 and 100 μM amiloride, respectively [47] . These observations are consistent with the amiloride sensitivity of the wild-type NCI-H441 cells in our hands, where 10 μM amiloride was sufficient to inhibit the main portion of the I SC (~90 %), and merely~5 % of the basal currents showed additional sensitivity to 100 μM amiloride. In δ 1 -ENaC overexpressing NCI-H441 cells, on the other hand, only~25 % of the basal I SC were inhibited by addition of 10 μM amiloride. An additional 55 % were sensitive to 100 μM amiloride. Importantly, the contribution of sodium currents to the total I SC was similar in both cell types, as demonstrated by inhibition of Na + /K + -ATPase by ouabain. These results suggest that the amiloride-refractory NSC channels account for a larger portion of the total sodium current and thus for a larger portion of the surface channel population in the transfected NCI-H441 cells.
Moreover, currents stimulated by the alleged δ-ENaC activators were, at least partially, insensitive to 10 μM amiloride, since both compounds were able to produce significant I SC increases in the monolayers pre-treated with 10 μM amiloride. Furthermore, the stimulatory effects were completely abolished by application of 100 μM amiloride or 300 μM EB. Thus, the interdependencies of the inhibitors, amiloride and EB, with the activators, capsazepine and icilin, were consistent with the assumption that the compounds interacted with the same target, i.e. δ-ENaC.
Conclusions
This work confirmed δ-ENaC expression in human respiratory epithelial NCI-H441 cell line and human alveolar epithelial cells in primary culture. The presence of δ-ENaC in human bronchial epithelial Calu-3 cell line was described for the first time. However, the abundance of δ-ENaC protein was very low, and δ-ENaC protein expression was not detected in the apical cell membrane. More importantly, this study demonstrated that, despite its expression in human respiratory epithelial cells in vitro, δ-ENaC function was not evident in the chosen airway epithelial cell models. Thus, the relevant contribution of endogenous δ-ENaC to net transepithelial sodium transport across respiratory epithelium, as suggested by studies in heterologous expression systems, could not be confirmed.
Since our work focused on the transepithelial ion movement under basal, unstimulated conditions, future investigations are required to clarify whether δ-ENaC function can be up-regulated in human airway epithelium. Moreover, based on our findings, the specificity of currently available pharmacological tools for characterisation of δ-ENaC function are highly unsatisfactory due to their interference with multiple transporter targets. Therefore, there is demand for more specific pharmacological modulators of δ-ENaC function that would help specifically dissect the contribution of the δ-subunit to ENaC-mediated sodium transport and elucidate the physiological role of δ-ENaC in the human lung and other tissues.
